Dr. Merchant is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-243-4902Fax+1 305-243-4907
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1996 - 1998
- Temple University HospitalResidency, Surgery, 1990 - 1996
- State University of New York Downstate Medical Center College of MedicineClass of 1990
Certifications & Licensure
- FL State Medical License 2015 - 2025
- TN State Medical License 2001 - 2016
- MD State Medical License 1998 - 2001
- NY State Medical License 1996 - 1998
- PA State Medical License 1992 - 1996
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca Start of enrollment: 2005 Oct 01
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients Start of enrollment: 2002 Jun 01
- Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas Start of enrollment: 2020 Feb 18
- Join now to see all
Publications & Presentations
PubMed
- 62 citationsStandardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 TrialMatthew H.G. Katz, Nipun B. Merchant, Steven T. Brower, Megan E. Branda, Mitchell C. Posner
Annals of Surgical Oncology. 2011-02-01 - 107 citationsNFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12.Bharti Garg, Bhuwan Giri, Shrey Modi, Vrishketan Sethi, Iris Castro
Gastroenterology. 2018-09-01 - 255 citationsPancreatic Adenocarcinoma, Version 2.2014Margaret A. Tempero, Mokenge P. Malafa, Stephen W. Behrman, Al B. Benson, Ephraim S. Casper
Journal of the National Comprehensive Cancer Network. 2014-08-01
Press Mentions
- Sylvester Researchers Identify Neutrophils as Major Culprits in Treatment Resistance of Pancreatic CancerMarch 22nd, 2023
- Sylvester Pancreatic Cancer Research Institute Takes on the Toughest TumorsApril 19th, 2022
- Sylvester Surgeon Receives Elsa Pardee Foundation GrantAugust 6th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: